Down’s syndrome (DS) is the most common chromosomal abnormality seen in live born children and it is the most common genetic cause of intellectual disability. It is associated with abnormalities in many body systems, some of which can cause life threatening complications. This article aims to cover the important aspects to cover when seeing children with DS for their routine follow-up in the neurodevelopmental or general paediatric clinic.
Statistics from Altmetric.com
Down’s syndrome (DS) occurs in 1 in every 1000 live births1 and is the most frequent chromosomal abnormality seen in liveborn infants. It is caused by having an extra full or partial copy of chromosome 21 in some or all of the body’s cells. DS is associated with a wide range of health conditions affecting multiple body systems. It is important that the care of children with DS is standardised so that complications are not missed. The Down Syndrome Medical Interest Group (DSMIG) has very useful guidelines for when and what type of screening should occur.
Children with DS should ideally be cared for by a paediatrician with expertise in DS (this could include a community paediatrician, paediatrician with a neurodisability interest or general paediatrician).2
Children should be reviewed regularly in the first year of life, then yearly after this. Table 1 gives a suggested timetable for follow-up. Some of this care may be delivered in a nurse led clinic.
Children with DS should have access to a multidisciplinary neurodevelopmental team including speech and language therapy, physiotherapy, paediatric cardiologist (in the neonatal period), paediatric ophthalmologist and audiologist. A range of other medical specialist and allied healthcare professionals should be available if required.2
Children with DS should be screened for common associated conditions including cardiac, hearing, vision, thyroid dysfunction, growth, development and sleep disordered breathing. See figure 1 for the DSMIG recommended screening, taken from the personalised child health record DS insert. Box 1 contains a link to the DSMIG website and other useful sources of information.
At transition, care coordination should be taken on by a clearly defined person, usually a General Practitioner2.
Guidelines, resources and important sources of information
DSMIG website. https://www.dsmig.org.uk/ gives details of recommended routine medical surveillance and DS growth charts.
Down’s Syndrome Association/DSMIG have produced a series of downloadable patient/parent information sheets about common health issues. Downloadable at http://www.downs-syndrome.org.uk/for-families-and-carers/health-and-well-being/health-series/
The Personal Child Health Record Book (PCHR) Down Syndrome inserts. A 32-page supplement for the red book, produced by the DSMIG, updated January 2020, 5th edition. Downloadable at https://www.healthforallchildren.com/wp-content/uploads/2020/02/A5-Downs-charts.pdf
DSMIG, Down Syndrome Medical Interest Group.
Full review, what to include in history and examination
Growth and feeding.
Hearing and vision.
Unusual or recurrent infections.
Symptoms of cervical spine instability.
Upper airway symptoms and sleep disordered breathing.
Social support, benefits, disability living allowance (DLA), respite.
Dental hygiene and registration with a dentist.
Full system examination.
Plotting height, weight (and head circumference) on Down’s syndrome growth chart.
Examine for cervical spine instability (ensure the patient can fully flex and extend their neck, abnormal head posture).
There can be a lot to cover when seeing children with DS during their regular review. We have summarised some important points that should be covered at different age points in table 1. During the majority of regular appointments, a ‘full review’ is needed; please see box 2 for details of what to cover in the history and examination at each appointment.
Complications of DS
Table 2 is a summary of some of the key complications seen in DS. In the following section, we will discuss these in more detail. It is important for anyone seeing children with DS to be aware of these.
Children with DS usually have delayed early development. The Personal Child Health Record Book DS insert contains useful tables to give indications of the typical ages for developmental milestones.
Intellectual disability in children with DS ranges from mild to profound.3 Speech and language difficulties are usually more pronounced than other areas, with greater difficulties in expressive language compared with receptive language.3 Deficits in working memory are also more marked. Studies have shown that children with DS who are offered a ‘rich’ developmental environment can have significantly improved IQ scores.3 This should be offered from birth.
Seizures occur in around 5%–6% of patients with DS, 40% of these patients present in infancy.4 The most common types of seizures are infantile spasms and then tonic clonic seizures with myoclonus.4 Children with DS have a relatively better prognosis and response to treatment than other causes of infantile spasms.5
Mental health and neurodevelopmental disorders
In the past, psychiatric and neurodevelopmental disorders in children with intellectual disability were minimised or felt to be a consequence of the underlying developmental disorder. We have since come to acknowledge the high prevalence of these issues in people with DS with at least half of all children and adults experiencing a major mental health issue during their lives.5 The most common issues include general anxiety, obsessive-compulsive behaviours, neurodevelopmental disorders, depression and sleep related disorders.5 Children with DS are particularly sensitive to changes in their environment, including chronic illness or loss of a family member, death of a household pet or absence of a teacher.5 New behavioural symptoms can also be a manifestation of an underlying medical disorder such as hypothyroidism, sleep problems or bowel related issues.
Autism spectrum disorders (ASD) are present in around 16% of children with DS, much higher than in the general population.6 Compared with other children with ASD, children with DS and ASD tend to have similar difficulties with communication and repetitive and stereotyped behaviours, but better reciprocal social interaction skills and less peer related and emotional problems.6
Symptoms of ADHD are also prevalent in children with DS. If inattention, impulsivity and hyperactivity are disproportionate with the mental age and result in significant impairment to academic or social development, then this diagnosis should be explored.
DS is the most common genetic condition associated with congenital heart disease (CHD)7 with CHD diagnosed in approximately 50% of children.8 Atrioventricular septal defect is the most common defect followed by atrial septal defects, ventricular septal defects and tetralogy of Fallot. All neonates with DS should be seen by a cardiologist and have an echocardiogram within the first 6 weeks of life, preferably within the first 2 weeks in high risk infants.9 Children with DS can develop pulmonary hypertension and develop right sided problems secondary to airway and respiratory problems.10 In later childhood, mitral valve prolapse and aortic regurgitation can develop. The DSMIG recommends yearly cardiac auscultation to identify emerging cardiac problems.9
Delayed growth and short stature are common features of DS. A suggested mechanism for this is growth hormone deficiency, secondary to hypothalamic dysfunction.10 DS-specific growth charts should be used to ensure children are following an appropriate growth trajectory. Routine use of growth hormone is not recommended, as it does not improve developmental outcomes.11 Up to ¾ of children with DS are overweight or obese.12 The underlying causes are thought to be linked to increased leptin, more sedentary behaviour, unfavourable diet and lack of exercise.12 Increasing weight gain usually starts after around 2 years of age.12
Patients with DS are more likely to have low bone mineral density, due to factors including low physical activity, decreased muscle mass, malabsorption syndromes, antiepileptic medication, low calcium and vitamin D3. Enhanced physical activity is recommended to optimise bone health.10
Vitamin D deficiency is more common due to a variety of mechanisms including poor intake of vitamin D, reduced sunlight exposure, poor absorption from coeliac disease and increased breakdown associated with anticonvulsants. No specific recommendations exist to advise supplementation in children with DS; however, there is an argument that it is beneficial to optimise growth and musculoskeletal development.10
Hypothyroidism in people with DS can be congenital or acquired. In a study of 85 people aged 0–25 years with DS, 33% developed hypothyroidism in a 15-year period.13 Around 50% also have subclinical hypothyroidism, indicated by high thyroid stimulating hormone (TSH) but normal T3/T4.14 Hyperthyroidism is also seen more frequently than in the normal population.10 Children need yearly screening from the age of one, more frequently before this.
Delayed puberty is a common feature of DS in both sexes.10 Girls can get delayed menarche and adrenarche. Boys have been reported to have ambiguous genitalia, cryptorchidism, micropenis and small testes.
Children with DS have a 150-fold increased risk of myeloid leukaemia (known as myeloid leukaemia of DS), it is nearly always diagnosed before 5 years of age and it is preceded by transient leukaemia of Down Syndrome (TL-DS), (previously known as transient abnormal myelopoiesis) as an infant.15 Children with DS also have a 30 fold increased risk of acute lymphoblastic leukaemia.15
Hirschsprung disease affects around 2% of children with DS.16 If children fail to pass meconium after birth and have recurrent issues with constipation, vomiting and abdominal distention then consider a possibility of Hirschsprung disease or an as yet undiagnosed gastrointestinal stenosis.
Gastro-oesophageal reflux occurs frequently due to reduced lower oesophageal tone and being slower to be able to sit up. Consider aspiration pneumonia if children present with chronic cough and recurrent pneumonia.16
Coeliac disease is present in around 5% of the DS population;17 there are some advocates of including regular screening in the surveillance programme, using either regular coeliac serology or human leukocyte antigen (HLA) screening. This is not currently recommended by the DSMIG and testing should be guided by clinical symptoms and risk (eg, positive family history).
Refractive errors, squints, abnormalities in accommodation, nystagmus, congenital cataracts and infant glaucoma are all more common in children with DS.9 Examination of the child’s visual system should be taken at each review, including in younger children looking for squint, abnormalities in gaze, visual behaviour and attention. They should have a formal ocular/visual assessment by an orthoptist and ophthalmologist or optometrist at 18–24 months, but if abnormalities are evident before this, earlier referral should be made.9 One-third of children will have a ocular/visual defect detected at this time.9 Due to the high prevalence of visual disorders, there is a specific screening programme recommended (see table 2).
Obstructive sleep apnoea is seen in half to three quarters of children with DS. Predisposing anatomical abnormalities including midface hypoplasia, large tongue and mandibular hypoplasia combined with relatively large tonsils and adenoids, leads to airway obstruction.18 Sleep-related breathing disorders result in nocturnal hypoxaemia, which can result in pulmonary hypertension. The presence of a CHD compounds this risk. See box 3 for the symptoms of sleep disordered breathing.
Symptoms of sleep disordered breathing
Sleep disturbance and odd sleeping positions (such as hanging over the side of the bed).
Mouth breathing and halitosis, dry mouth on waking.
Recurrent upper respiratory tract infections.
Nausea and vomiting.
Persistent or secondary enuresis.
Cyanosis and apnoea.
Children with DS should have screening for a sleep-related breathing disorder by enquiring about the above symptoms. The DSMIG recommend yearly screening with overnight oximetry until 5 years of age, but this will be guided by local availability. Those with suggestive symptoms should have overnight oximetry and referral to ENT. Those whose results are abnormal, or there is suspicion of a false negative should have a more detailed sleep study with polysomnography including oximetry, airflow, effort and CO2 measurement. Adenotonsillectomy may be of benefit and continuous positive airway pressure can be used to treat it.
Over 50% of people with DS have a significant hearing impairment, with sensorineural and or conductive hearing loss being present at all ages.9 Otitis media with effusion is the most common cause of conductive hearing loss.9 All babies should have a full audiological assessment at 6–10 months of age and a regular programme of screening should be in place after this (see table 2).
Children with DS are at increased risk of infections, due to abnormalities of their immune systems and anatomical differences. Immune system abnormalities include mild to moderate T and B cell lymphopaenia, with abnormal T cell proliferation, reduced response to vaccination and defects of neutrophil chemotaxis.19 Infections may be serious and present atypically compared with non-DS children.
Anatomical abnormalities of the airway like laryngomalacia and tracheomalacia, impaired clearance of secretions, increased gastro-oesophageal reflux and aspiration are the mechanisms leading to increased lower respiratory tract infections. The ENT abnormalities in the above section also predispose to respiratory tract and ear infections.
Lower respiratory tract infections are a frequent reason for children with DS to be admitted to hospital, and the most common reason to be admitted to intensive care.
In children with history of recurrent, severe or atypical infections a referral to the local immunology team should be considered. They may advise longer antibiotic courses, additional vaccination and occasionally prophylactic antibiotics.
Normal routine vaccinations are recommended plus consideration of annual influenza vaccine and pneumococcal polysaccharide vaccine.
Inflammatory arthritis is 18–21 times more common in people with DS,9 and the diagnosis is often missed due to having a higher pain threshold, so there should be a low index of suspicion. People with DS have lower muscle tone and hyperflexibility.10
There is an increased susceptibility of people with DS to get craniovertebral instability due to hypotonia and ligamentous laxity. This occurs between atlas and axis (atlantoaxial subluxation) and also between occiput and atlas (occipito-atlantal subluxation).
Warning signs of craniovertebral instability include9
Abnormal head posture including torticollis.
Reduced neck movement.
Deterioration of manipulative skills.
Deterioration of gait and frequent falls.
Increased fatigability on walking.
If these signs are present and no alternative is found to explain the symptoms, a cervical spine x-ray in flexion and extension should be performed.9 There is no good evidence that x-rays in asymptomatic children are useful.
The DS charities advocate a ‘people first’ approach to our language around people with DS. Using certain terminology such as ‘Down’s baby/child’ or describing DS as a ‘disease/handicap or illness’ are incorrect. Instead, saying that a they are a ‘baby with Down’s syndrome’ and describing it as a ‘condition’ are factually correct and more sensitive.
Children with DS may have additional communication needs, so it is important to speak clearly and if possible use visual aids. Remember that a child’s parents know the most about their child and are a valuable source of information, particularly when they are acutely unwell, always listen to the parents!
Clinical bottom line
Children with DS can develop a range of medical disorders linked to their condition, and it is important that clinicians caring for children in the community are aware of these complications.
Screening pathways exist to monitor for abnormalities in the following systems: cardiac, hearing, vision, thyroid dysfunction, growth, development and sleep disordered breathing.
Patient consent for publication
Many thanks to Varshali Swadi and Jo Hughes from Down Syndrome Scotland, who reviewed the article and advised further changes.
Correction notice This article has been corrected since it first published. The provenance and peer review statement has been included.
Contributors RAD came up with the concept of the article and wrote the article. NM, SH and LHS edited and added to the article.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.